Alliance Healthcare (AIQ) Reaffirms FY11 Guidance; Offers FY12 Outlook
Tweet
Share
E-mailGet Alerts AIQ Hot Sheet
Price: $64.07 -0.23%
Financial Fact:
Less: Net income attributable to noncontrolling interest: -4.47M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Less: Net income attributable to noncontrolling interest: -4.47M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Alliance Healthcare (NYSE: AIQ) reaffirms its FY11 sales outlook of $475-$495 million.
Sees FY12 sales $470-$500 million, which compares to the Street estimate of $505.94 million. Sees adj-EBITDA of $140-$160 million.
Sees FY12 sales $470-$500 million, which compares to the Street estimate of $505.94 million. Sees adj-EBITDA of $140-$160 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
- HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
- Lucky Strike Entertainment Corporation (LUCK) reported Q2 Revenue ; Offers Guidance
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
